Keywords: ترولیدازون; 2D-sw; 2D-sandwich; AMI; amiodarone; APAP; acetaminophen; BA; bile acid; BC; bile canaliculi; BOS; bosentan; BSEP; bile salt export pump; CPZ; chlorpromazine; CSA; cyclosporine A; CYP450; cytochrome P450; DIC; drug-induced cholestasis; DICI; drug-induced
مقالات ISI ترولیدازون (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ترولیدازون; Î2-TGZ; Î2-Troglitazone; TGZ; Troglitazone; TZD; Thiazolidinediones; RGZ; Rosiglitazone; 2-DG; 2-deoxyglucose; ER; endoplasmic reticulum; CGZ; Ciglitazone; UPR; unfolded protein response; Cancer; Glucose metabolism; 2-deoxyglucose, Thiazolidinediones; W
Keywords: ترولیدازون; Troglitazone; PPARγ; Hypoxia; Kidney
The influence of peroxisome proliferator-activated receptor γ (PPARγ) ligands on cancer cell tumorigenicity
Keywords: ترولیدازون; Cancer cells; PPARγ agonist; PPARγ antagonist; Therapeutic agents; Tumorigenicity; ACC; Acetyl-CoA carboxylase; AKR1B10; Alde-keto reductase 1B10; Alpha-ESA; Alpha-eleostreac acid; ACLY; ATP citrate lyase; BADGE; Bisphenol-A-diglycidyl-etter; CSCs; Canc
Human iPS derived progenitors bioengineered into liver organoids using an inverted colloidal crystal poly (ethylene glycol) scaffold
Keywords: ترولیدازون; Biomimetic materials; Liver stem cells; Bioengineering; Organogenesis; iPSC; induced pluripotent stem cell; IH; iPSC derived hepatic progenitors; FDA; food and drug administration; TGFβ; transforming growth factor beta; 3D; three-dimensional; ICC; invert
Untying the knot of transcription factor druggability: Molecular modeling study of FOXM1 inhibitors
Keywords: ترولیدازون; FOXM1; Thiostrepton; Thiazolidinediones; Troglitazone;
Inhibition of ERK activity enhances the cytotoxic effect of peroxisome proliferator-activated receptor γ (PPARγ) agonists in HeLa cells
Keywords: ترولیدازون; PPARγ; Ciglitazone; Troglitazone; Cervical cancer; Apoptosis;
The effects of troglitazone on AMPK in HepG2 cells
Keywords: ترولیدازون; AMPK; Troglitazone; Thiazolidinedione; HepG2; Diabetes; Ser485/491;
PPARα, PPARγ and SREBP-1 pathways mediated waterborne iron (Fe)-induced reduction in hepatic lipid deposition of javelin goby Synechogobius hasta
Keywords: ترولیدازون; ACC; acetyl-CoA carboxylase; ANOVA; one-way analysis of variance; CF; condition factor; CPT; carnitine palmitoyltransferase; DMSO; dimethyl sulphoxide; F; fatostatin; FAS; fatty acid synthase; Fe; iron; G6PD; glucose 6-phosphate dehydrogenase; GW; GW6471;
Troglitazone, a PPAR-γ agonist, decreases LTC4 concentration in mononuclear cells in patients with asthma
Keywords: ترولیدازون; Asthma; PPAR-γ; Troglitazone;
Study of new interactions of glitazone's stereoisomers and the endogenous ligand 15d-PGJ2 on six different PPAR gamma proteins
Keywords: ترولیدازون; Pioglitazone (PubChem CID: 4829); Rosiglitazone (PubChem CID: 77999); Troglitazone (PubChem CID: 29010888); 2,4-Thiazolidinedione (PubChem CID: 5437); 15d-PGJ2 (PubChem CID: 5311211); Docking; Molecular dynamics; Pioglitazone; Rosiglitazone; Troglitazone;
Activation of peroxisome proliferator-activated receptor gamma in mammary epithelial cells upregulates the expression of tumor suppressor Cyld to mediate growth inhibition and anti-inflammatory effects
Keywords: ترولیدازون; Cyld; Troglitazone; PPAR-γ; Promoter; Inflammation;
Cryptotanshinone, a compound of Salvia miltiorrhiza inhibits pre-adipocytes differentiation by regulation of adipogenesis-related genes expression via STAT3 signaling
Keywords: ترولیدازون; Cryptotanshinone; Adipogenesis; C/EBPβ; PPARγ; STAT3; CT; cryptotanshinone; RA; retinoic acid; Tro; troglitazone; C/EBP; CCAAT/enhancer-binding protein; PPARγ; peroxisome proliferation-activity receptor γ; GAPDH; glycerol-3-phosphate dehydrogenase; IB
Quercetin metabolites inhibit MMP-2 expression in A549 lung cancer cells by PPAR-γ associated mechanisms
Keywords: ترولیدازون; Q3G; Quercetin-3-glucuronide; Q3â²S; Quercetin-3â²-sulfate; TGZ; Troglitazone; MMP-2; Matrix metalloproteinases-2; PPAR-γ; Peroxisome proliferator-activated receptor gamma; TIMP-2; Tissue inhibitor of metalloproteinase 2; QP; quercetin-metabolite-enric
Inhibitory effects of PPARγ ligands on TGF-β1-induced CTGF expression in cat corneal fibroblasts
Keywords: ترولیدازون; Rosiglitazone; Troglitazone; 15d-PGJ2; JNK; p38 MAPK; ERK; AKT; CTGF; connective tissue growth factor; CCN; cyr61, ctgf, neuroblastoma over-expressed gene; Nov; neuroblastoma over-expressed gene; ECM; extracellular matrix; PRK; photorefractive keratectomy
Structural insight of glitazone for hepato-toxicity: Resolving mystery by PASS
Keywords: ترولیدازون; Troglitazone; Glitazone; PASS; Apoptosis; Docking; Immunoblot analysis
In Vitro Evaluation of Hypoglycemic Agents to Target Human Islet Amyloid Polypeptide: A Key Protein Involved in Amyloid Deposition and Beta-Cell Loss
Keywords: ترولیدازون; antiamyloidogenic agents; hIAPP; human islet amyloid polypeptide; repaglinide; troglitazone; type 2 diabetesagents antiamyloïdogènes; hIAPP (human islet amyloid polypeptide); polypeptide amyloïde d’îlots pancréatiques humains; répaglinide; troglitazone; d
The histone deacetylase inhibitor cambinol prevents acidic pHe-induced anterograde lysosome trafficking independently of sirtuin activity
Keywords: ترولیدازون; SIRT; sirtuin; NHE; sodium proton exchanger; Tro; troglitazone; JLA; juxtanuclear lysosome aggregation; EIPA; ethyl-isopropyl amiloride; LAMP-1; lysosome associated membrane protein 1; HDAC; histone deacetylase; pHe; extracellular pH; MTOC; microtubule or
Stimulating basal mitochondrial respiration decreases doxorubicin apoptotic signaling in H9c2 cardiomyoblasts
Keywords: ترولیدازون; Doxorubicin; H9c2 myoblasts; Mitochondrial capacity; Toxicity; Troglitazone;
Transcriptomics hit the target: Monitoring of ligand-activated and stress response pathways for chemical testing
Keywords: ترولیدازون; AD; adefovir dipivoxil; AhR; aryl hydrocarbon receptor; AMIO; amiodarone; APAP; acetaminophen; ATF4; activating transcription factor 4; CAA; chloroacetaldehyde; CdCl2; cadmium chloride; ChIP-seq; chromatin immunoprecipitation followed by DNA sequencing; C
Cytotoxicity of thiazolidinedione-, oxazolidinedione- and pyrrolidinedione-ring containing compounds in HepG2 cells
Keywords: ترولیدازون; Clustering; Cytotoxicity; HepG2 cells; Molecular fingerprints; Oxazolidinedione; Pyrrolidinedione; Succinimide; Thiazolidinedione; Troglitazone;
Acute exposure of beta-cells to troglitazone decreases insulin hypersecretion via activating AMPK
Keywords: ترولیدازون; AMPK; AMP-activated protein kinase; TZD; thiazolidinediones; IGT; impaired glucose tolerance; IFG; impaired fasting glucose; GSIS; glucose-stimulated insulin secretion; ACC; acetyl-CoA carboxylase; PPARγ; peroxisome proliferator-activated receptor γ; sh
Optimization of troglitazone derivatives as potent anti-proliferative agents: Towards more active and less toxic compounds
Keywords: ترولیدازون; Troglitazone; Chromane; Cancer; Hepatotoxicity
Application of exogenous mixture of glutathione and stable isotope labeled glutathione for trapping reactive metabolites in cryopreserved human hepatocytes. Detection of the glutathione conjugates using high resolution accurate mass spectrometry
Keywords: ترولیدازون; Glutathione conjugation; Troglitazone; Reactive metabolites; Stable isotope label; LC–HRAMS; Human hepatocytes
Glitazones in chronic kidney disease: Potential and concerns
Keywords: ترولیدازون; Glitazones; Thiazolidinediones; Rosiglitazone; Pioglitazone; Troglitazone; Chronic kidney disease; Cardiovascular outcomes; Albuminuria
Synthesis of new troglitazone derivatives: Anti-proliferative activity in breast cancer cell lines and preliminary toxicological study
Keywords: ترولیدازون; Troglitazone; Chromane; Breast cancer; Hepatotoxicity
Chimeric mice with a humanized liver as an animal model of troglitazone-induced liver injury
Keywords: ترولیدازون; Chimeric mouse with a humanized liver; Drug-induced liver injury (DILI); Hepatotoxicity; Troglitazone; Glutathione
Evaluation of PPARγ agonists on rodent endothelial cell proliferation
Keywords: ترولیدازون; PPARγ agonist; Troglitazone; Pioglitazone; Hemangiosarcoma; Endothelial cell proliferation; Rodent
Cytotoxicity of troglitazone through PPARγ-independent pathway and p38 MAPK pathway in renal cell carcinoma
Keywords: ترولیدازون; Troglitazone; PPARγ; Renal cell carcinoma; Apoptosis; p38 MAPK;
Brazilian propolis-derived components inhibit TNF-α-mediated downregulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes
Keywords: ترولیدازون; aP2; adipocyte fatty acid-binding protein 4; EMM; molecular mechanics energy; FBS; fetal bovine serum; JNK; c-Jun-NH2-terminal kinase; MAPK; mitogen-activated protein kinase; MKK; mitogen-activated protein kinase kinase; MM-PBSA; molecular mechanics Poiss
Identification of novel monoamine oxidase B inhibitors by structure-based virtual screening
Keywords: ترولیدازون; MPTP; Pioglitazone; Rosiglitazone; Ciglitazone; Troglitazone; Amplex Red; KNIME; MOE-Dock; ERK kinase; PPAR-γ
Repression of β-catenin signaling by PPARγ ligands
Keywords: ترولیدازون; PPARγ; β-Catenin; Troglitazone; Rosiglitazone; GW1929 (N-(2-Benzoylphenyl)-O-[2-(methyl-2-pyridinylamino)ethyl]-l-tyrosine hydrochloride)
Troglitazone is an estrogen-related receptor α and γ inverse agonist
Keywords: ترولیدازون; Troglitazone; ERRα; ERRγ; Mitochondrial biogenesis; ROS
Troglitazone stimulates β-arrestin-dependent cardiomyocyte contractility via the angiotensin II type 1A receptor
Keywords: ترولیدازون; PPARγ; Troglitazone; AT1AR; β-Arrestin; Cardiomyocyte; Contractility
Direct toxicity effects of sulfo-conjugated troglitazone on human hepatocytes
Keywords: ترولیدازون; Troglitazone; Troglitazone sulphate; Human hepatocytes; Glutathione; In vitro cell toxicity; Oxidative stress
Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts
Keywords: ترولیدازون; Peroxisome Proliferator-Activated Receptor-γ; Troglitazone; Transforming growth factor-β1; Collagen I; Fibronection; Dermal fibrosis
Investigation of the role of the thiazolidinedione ring of troglitazone in inducing hepatotoxicity
Keywords: ترولیدازون; Troglitazone; Reactive metabolites; Hepatotoxicity; Glutathione; Human hepatocytes; Thiazolidinedione
Troglitazone inhibits histone deacetylase activity in breast cancer cells
Keywords: ترولیدازون; Troglitazone; Breast cancer; Histone post-translational modifications; Cell killing; PI3K/AKT inhibition
Troglitazone increases expression of E-cadherin and claudin 4 in human pancreatic cancer cells
Keywords: ترولیدازون; Troglitazone; Pancreatic cancer; Invasion; E-cadherin; Claudin 4; MEK-ERK signaling;
Thiazolidinediones Downregulate Wnt/β-Catenin Signaling Via Multiple Mechanisms in Breast Cancer Cells
Keywords: ترولیدازون; PPARγ; thiazolidinedione; troglitazone; breast cancer; Wnt; β-catenin; TCF4; frizzled-1; LRP6; Akt
Production of a reactive metabolite of troglitazone by electrochemical oxidation performed in nonaqueous medium
Keywords: ترولیدازون; Troglitazone; Reactive drug metabolite; Electrochemical oxidation; Nonaqueous medium; LC-MS
Effects of the PPARγ agonist troglitazone on endothelial cells in vivo and in vitro: Differences between human and mouse
Keywords: ترولیدازون; PPARγ; Troglitazone; Endothelial cell; Proliferation; Apoptosis; Hemangiosarcoma;
Species-specific toxicity of diclofenac and troglitazone in primary human and rat hepatocytes
Keywords: ترولیدازون; Primary hepatocytes; Diclofenac; Troglitazone; Cytotoxicity; Gene expression
PPARγ ligands suppress the feedback loop between E2F2 and cyclin-E1
Keywords: ترولیدازون; PPARγ; Wnt signal; Troglitazone; E2F2; Cyclin-E1
Evaluation of dispersion state of the two racemic compounds of troglitazone in pharmaceutical granules using IR-to-THz imaging
Keywords: ترولیدازون; Solid dispersion; Troglitazone; Racemic compounds; Polyvinylpyrrolidone; IR-to-THz imaging; Chemo-metrics
Troglitazone up-regulates vascular endothelial argininosuccinate synthase
Keywords: ترولیدازون; Vascular endothelial cells; Nitric oxide; Argininosuccinate synthase; Troglitazone; Citrulline–nitric oxide cycle
Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor γ (PPARγ) ligand
Keywords: ترولیدازون; PPARγ ligand; Troglitazone; Apoptosis; Cell cycle;
Evaluation of solid dispersions on a molecular level by the Raman mapping technique
Keywords: ترولیدازون; Troglitazone; Raman spectroscopy; Raman mapping technique; Solid dispersion
Troglitazone acutely activates AMP-activated protein kinase and inhibits insulin secretion from beta cells
Keywords: ترولیدازون; AMP-activated protein kinase; Troglitazone; Palmitate; Pancreatic beta cell; Insulin secretion; Acetyl-CoA carboxylase
PPARγ activation abolishes LDL-induced proliferation of human aortic smooth muscle cells via SOD-mediated down-regulation of superoxide
Keywords: ترولیدازون; Atherosclerosis; Low-density lipoproteins; MAP kinase; PPAR; Smooth muscle cell; Superoxide; Troglitazone